These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 24314655)
1. microRNA expression in hepatitis B virus infected primary treeshrew hepatocytes and the independence of intracellular miR-122 level for de novo HBV infection in culture. Xu G; Gao Z; He W; Ma Y; Feng X; Cai T; Lu F; Liu L; Li W Virology; 2014 Jan; 448():247-54. PubMed ID: 24314655 [TBL] [Abstract][Full Text] [Related]
2. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes. König A; Döring B; Mohr C; Geipel A; Geyer J; Glebe D J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614 [TBL] [Abstract][Full Text] [Related]
3. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. Iwamoto M; Watashi K; Tsukuda S; Aly HH; Fukasawa M; Fujimoto A; Suzuki R; Aizaki H; Ito T; Koiwai O; Kusuhara H; Wakita T Biochem Biophys Res Commun; 2014 Jan; 443(3):808-13. PubMed ID: 24342612 [TBL] [Abstract][Full Text] [Related]
4. Property of hepatitis B virus replication in Tupaia belangeri hepatocytes. Sanada T; Tsukiyama-Kohara K; Yamamoto N; Ezzikouri S; Benjelloun S; Murakami S; Tanaka Y; Tateno C; Kohara M Biochem Biophys Res Commun; 2016 Jan; 469(2):229-35. PubMed ID: 26654952 [TBL] [Abstract][Full Text] [Related]
5. Suppression of hepatitis B virus replication in Tupaia hepatocytes by tumor necrosis factor alpha of Tupaia belangeri. Xu Y; Köck J; Lu Y; Yang D; Lu M; Zhao X Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):361-8. PubMed ID: 21684599 [TBL] [Abstract][Full Text] [Related]
6. Strategies to inhibit entry of HBV and HDV into hepatocytes. Urban S; Bartenschlager R; Kubitz R; Zoulim F Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection. Yan Y; Allweiss L; Yang D; Kang J; Wang J; Qian X; Zhang T; Liu H; Wang L; Liu S; Sui J; Chen X; Dandri M; Zhao J; Lu F Emerg Microbes Infect; 2019; 8(1):879-894. PubMed ID: 31179847 [TBL] [Abstract][Full Text] [Related]
9. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor. Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Walter E; Keist R; Niederöst B; Pult I; Blum HE Hepatology; 1996 Jul; 24(1):1-5. PubMed ID: 8707245 [TBL] [Abstract][Full Text] [Related]
11. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes. Lempp FA; Wiedtke E; Qu B; Roques P; Chemin I; Vondran FWR; Le Grand R; Grimm D; Urban S Hepatology; 2017 Sep; 66(3):703-716. PubMed ID: 28195359 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes. Baumert TF; Yang C; Schürmann P; Köck J; Ziegler C; Grüllich C; Nassal M; Liang TJ; Blum HE; von Weizsäcker F Hepatology; 2005 Feb; 41(2):247-56. PubMed ID: 15660384 [TBL] [Abstract][Full Text] [Related]
13. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. Köck J; Nassal M; MacNelly S; Baumert TF; Blum HE; von Weizsäcker F J Virol; 2001 Jun; 75(11):5084-9. PubMed ID: 11333889 [TBL] [Abstract][Full Text] [Related]
14. Interleukin 6 inhibits HBV entry through NTCP down regulation. Bouezzedine F; Fardel O; Gripon P Virology; 2015 Jul; 481():34-42. PubMed ID: 25765005 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors. Ren S; Nassal M J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483 [TBL] [Abstract][Full Text] [Related]
16. A cross-talk between Hepatitis B virus and host mRNAs confers viral adaptation to liver. Hu J; Xu Y; Li C; Hao J; Peng S; Chu X; Zhang D; Xu D; Meng S Sci Rep; 2015 Jul; 5():10572. PubMed ID: 26184825 [TBL] [Abstract][Full Text] [Related]
19. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication. Qiao L; Sui J; Luo G J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184 [TBL] [Abstract][Full Text] [Related]
20. Advances and Challenges in Studying Hepatitis B Virus In Vitro. Witt-Kehati D; Bitton Alaluf M; Shlomai A Viruses; 2016 Jan; 8(1):. PubMed ID: 26784218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]